Josh Fischman

@jfischman.bsky.social

Senior editor and special projects editor. Formerly Scientific American and health podcast host. Stories on health, biology, science & politics, cute animals

This year @nature.com published a gene therapy study showing success in mice and monkeys. It did not mention a little girl died from the treatment. That death is in a new @science.org story on the tragedy: bit.ly/4fCAvkk. Nature has not updated the article. The dead girl's family has complained. 🧪

In vivo base editing of Chd3 rescues behavioural abnormalities in mice - Nature

In vivo base editing of a causative mutation that leads to the neurodevelopmental disorder Snijders Blok–Campeau syndrome restores protein dosage and ameliorates molecular and behavioural deficits in ...

nature.com

An eventful week at Scientific American. Owner Springer Nature rushed to sell SciAm 3 days before the staff overwhelmingly voted to form a union, and laid off a lot of people. Including me. I got to work with amazing writers during my time, people who made me better. Thank-you list in comment below:

Late Sunday musing: Changed my LinkedIn status to "open to work" last week (see thumbnail for why). Suddenly flooded with invites from "executives known for transforming organizations." Big common profile phrase. If there's so much transformation, why do orgs stay the same? (Or get worse.)

#opentowork | Josh Fischman | 27 comments

Hi! I’m interested in a new role, or a different job, as Scientific American was just sold and the future there seems difficult. If you hear of any opportunities or just want to catch up, please send ...

linkedin.com

An eventful week at Scientific American. Owner Springer Nature rushed to sell SciAm 3 days before the staff overwhelmingly voted to form a union, and laid off a lot of people. Including me. I got to work with amazing writers during my time, people who made me better. Thank-you list in comment below:

Worth reading this project. Framing hostile to trans people is a bad problem. I wonder about the rubric fed to the LLMs & cause/effect assumptions. # of state laws that are anti-LGBTQ+ has shot up. Stories on the laws will show up as anti-trans in the rubric. Is that bias? Or reporting on the laws?

Alejandra Caraballo@esqueer.net · 2mo ago

I've spent the last two months putting together this exhaustive analysis of the New York Times coverage of trans people. It covers 3,242 articles over 12 years. In 2022, the NYT shifted towards a hostile stance towards trans people in their framing. www.thedissident.news/exclusive-ho...

I learned a lot about glow-in-the-dark brains and how neurons 'talk' from @adam-bowman.bsky.social . My story about his cool work is in @sciam.bsky.social profiles of Young American Scientists, just out today! Thanks, Adam, for your patient explanations! 🧪

Scientific American@sciam.bsky.social · 2mo ago

Adam Bowman (@adam-bowman.bsky.social) is among the inaugural class of Scientific American's Young American Scientists. Explore his research: spklr.io/6009E3mjD Meet the other honorees on this year's list: sciam.com/youngscientists #SciAmYoungScientists

Illustration of Adam Bowman, a researcher at the Salk Institute for Biological Studies and a member of Scientific American's inaugural Young American Scientists class. The graphic lists his age as 30 and his field as biophysics.

Starbucks is selling protein-enhancing lattes. (I tried one. If you like gritty froth...) Pop-Tarts boasts of extra protein too. But this craze for extra protein in extra-processed foods isn't that healthy, @beebrookshire.bsky.social reports now in @sciam.bsky.social. 🧪 #medsky Read why:

Are protein-boosted foods and drinks actually more healthy?

Extra protein can be found in everything now, from potato chips to Pop-Tarts. Does this benefit the average eater?

scientificamerican.com

Hello, Bluesky! We, the staff of Scientific American, are pleased to announce we have formed a union with @wgaeast.bsky.social. Just as mitochondria are the powerhouse of the cell, we are the powerhouse of the publication, and we’re excited to have a new way to contribute to its success.